» Articles » PMID: 27959619

Macrophages and the Recovery from Acute and Chronic Inflammation

Overview
Publisher Annual Reviews
Specialty Physiology
Date 2016 Dec 14
PMID 27959619
Citations 168
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, researchers have devoted much attention to the diverse roles of macrophages and their contributions to tissue development, wound healing, and angiogenesis. What should not be lost in the discussions regarding the diverse biology of these cells is that when perturbed, macrophages are the primary contributors to potentially pathological inflammatory processes. Macrophages stand poised to rapidly produce large amounts of inflammatory cytokines in response to danger signals. The production of these cytokines can initiate a cascade of inflammatory mediator release that can lead to wholesale tissue destruction. The destructive inflammatory capability of macrophages is amplified by exposure to exogenous interferon-γ, which prolongs and heightens inflammatory responses. In simple terms, macrophages can thus be viewed as incendiary devices with hair triggers waiting to detonate. We have begun to ask questions about how these cells can be regulated to mitigate the collateral destruction associated with macrophage activation.

Citing Articles

Novel composite bone cement modulates inflammatory response in vitro.

Hao K, Hu J, Wang J, Li F Sci Rep. 2025; 15(1):8897.

PMID: 40087513 DOI: 10.1038/s41598-025-93575-4.


TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases.

Hui L, Chen X, Huang M, Jiang Y, Liu T Int J Mol Sci. 2025; 26(5).

PMID: 40076567 PMC: 11900955. DOI: 10.3390/ijms26051941.


Pedicled Latissimus Dorsi Flap Vascularized by a Lumbar Artery Perforator for the Reconstruction of an Exposed Lumbar Spinal Fixation Device: A Case Report.

Sakaguchi R, Sasaki K, Oshima J, Aihara Y, Sekido M Cureus. 2025; 17(1):e78163.

PMID: 40026939 PMC: 11870773. DOI: 10.7759/cureus.78163.


The Trim32-DPEP2 axis is an inflammatory switch in macrophages during intestinal inflammation.

Zhan Z, Liang H, Zhao Z, Pan L, Li J, Chen Y Cell Death Differ. 2025; .

PMID: 40021897 DOI: 10.1038/s41418-025-01468-w.


pH-responsive molybdenum disulphide composite nanomaterials for skin wound healing using "ROS leveraging" synergistic immunomodulation.

Yang Z, You J, Zhai S, Zhou J, Quni S, Liu M Mater Today Bio. 2025; 31:101481.

PMID: 39925719 PMC: 11804827. DOI: 10.1016/j.mtbio.2025.101481.


References
1.
Kalinski P . Regulation of immune responses by prostaglandin E2. J Immunol. 2011; 188(1):21-8. PMC: 3249979. DOI: 10.4049/jimmunol.1101029. View

2.
Chuang T, Ulevitch R . Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol. 2004; 5(5):495-502. DOI: 10.1038/ni1066. View

3.
Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G . Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 2005; 7(2):139-47. DOI: 10.1038/ni1294. View

4.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

5.
Serhan C, Chiang N, Dalli J . The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015; 27(3):200-15. PMC: 4515371. DOI: 10.1016/j.smim.2015.03.004. View